SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 trial reaching its 80th death triggered final analysis, putting the pending GPS survival readout in AML at the center of discussion. The sharp pullback has divided traders: some view it as a shakeout and continue buying, while others warn that the binary results could disappoint.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

UBSs upgrade of Rivian to Buy, citing the recent sell-off as an opportunity ahead of the R2 ramp, is driving attention. Traders are cheering the sharp rise and speculating about a short squeeze, while some remain cautious about the rallys staying power and execution risks.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to fund its AI infrastructure buildout are weighing on shares, with traders focused on dilution, rising debt, and the timing of the financing. Some argue the raise was already part of the companys disclosed capital plan and supports growth, while others see it as a sign of mounting funding risk.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with LITE holders set to receive a fixed number of Marvell shares rather than cash. Traders are focused on LITEs sharp decline as Marvell shares fall, debating whether the deal undervalues Lumentum and leaves shareholders exposed to Marvells price through a lengthy, approval-dependent closing process.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells announced all-stock acquisition of Lumentum to expand its AI data-center optics and connectivity business is driving discussion. Many traders view the deal as costly and heavily dilutive, contributing to selling in both stocks, while others see strategic value in combining Marvells chips and networking with Lumentums optical technology.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp decline is widely attributed to spillover from Intels disappointing outlook and broader concerns about semiconductor demand and AI spending, rather than a company-specific announcement. Ahead of AMDs earnings, traders disagree over whether Intels weakness signals a wider slowdown or creates an opportunity for AMD to gain share, with bulls calling the selloff overdone and bears worried about weak guidance.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is rebounding after its post-earnings selloff, with traders pointing to accelerating AWS growth and strong AI-cloud demand; a Phillip Securities upgrade added support. The debate remains whether those prospects justify heavy AI spending and negative free cash flow, or whether the cash burn and earnings misses warrant caution.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is selling off despite strong Q3 revenue growth and a narrower-than-expected loss, as investors focus on managements lack of quantified guidance, elevated costs, and uncertainty around the Alzheimers agitation launch and path to cash-flow positivity. Some holders view the decline as an overreaction to a solid quarter, while others want clearer evidence of launch traction and spending discipline.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstarts steep selloff and repeated 52-week lows dominate discussion, with traders focused on concerns about its debt, funding access and sensitivity to interest rates and credit conditions. Some see the decline as overdone and point to lending growth, partnerships and a potential bank charter, while others remain skeptical and expect continued pressure.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention ahead of the FDAs decision on deramiocel for Duchenne muscular dystrophy, with discussion focused on the refined upper-limb indication and recent launch-related job postings. Bullish traders read the hiring as a sign of confidence, while skeptics point to the prior advisory-panel concerns and caution that hiring does not guarantee approval.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PLTR reports after the bell today. The quarter itself feels mostly priced in at this point, so I&#39;ll be watching whether they lift the full-year outlook from the $8.15B to $8.16B range. At roughly 61x this year&#39;s expected revenue per RBC, there isn&#39;t much room for a soft guide.

Michael Alva

TopOptionsAlerts®

StockTwits Web

Palantir Technologies Inc

 reports after the bell today. The quarter itself feels mostly priced in at this point, so I'll be watching whether they lift the full-year outlook from the $8.15B to $8.16B range. At roughly 61x this year's expected revenue per RBC, there isn't much room for a soft guide.

@BuyTheDip WOW!!! Never heard this before........WOW!!

 WOW!!! Never heard this before........WOW!!